Vivo Capital »

Satellos Bioscience shares owned by Vivo Capital

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.6M 814k 5.63

More positions owned by Vivo Capital

Erasca Common (ERAS)
Praxis Precision Medicines Common (PRAX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
DBV Technologies SA Sponsored Ads (DBVT)
Compass Therapeutics Common (CMPX)
Tango Therapeutics Common (TNGX)
SAB Biotherapeutics Common (SABS)
Corvus Pharmaceuticals Holdings Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Dianthus Therapeutics Common (DNTH)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Minerva Neurosciences Common (NERV)

View all positions for Vivo Capital

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience